Max Konig, MD

Assistant Professor
Johns Hopkins University

Poster(s):

• 343 - Treatment of Post-COVID-19 POTS by inhibiting FcRn: A phase 2 randomized, placebo controlled, double-blind, proof of concept study with efgartigimod
  Friday, February 23, 2024

  5:00 PM – 6:30 PM EDT